Dr. Agarwal’s Health Care Limited IPO (Dr Agarwals Healthcare IPO) Detail

Dr Agarwals Healthcare IPO is a book built issue of Rs 3,027.26 crores. The issue is a combination of fresh issue of 0.75 crore shares aggregating to Rs 300.00 crores and offer for sale of 6.78 crore shares aggregating to Rs 2,727.26 crores.

Dr Agarwals Healthcare IPO bidding started from January 29, 2025 and ended on January 31, 2025. The allotment for Dr Agarwals Healthcare IPO was finalized on Monday, February 3, 2025. The shares got listed on BSE, NSE on February 4, 2025.

Dr Agarwals Healthcare IPO price band is set at ₹402 per share. The minimum lot size for an application is 35. The minimum amount of investment required by retail investors is ₹13,370. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹14,070. The minimum lot size investment for sNII is 15 lots (525 shares), amounting to ₹2,11,050, and for bNII, it is 72 lots (2,520 shares), amounting to ₹10,13,040.

Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited are the book running lead managers of the Dr Agarwals Healthcare IPO, while Kfin Technologies Limited is the registrar for the issue.

Refer to Dr Agarwals Healthcare IPO RHP for detailed information.

Dr. Agarwal’s Health Care Limited Stock Quote & Charts

• Open: ₹448.60
• High – Low: ₹458.45 – ₹442.00
• Previous Close: ₹442.80
• Total Traded Value: 3,18,735.00
• 52 Weeks High: ₹464.00 (Feb 13, 2025)
• 52 Weeks Low: ₹365.70 (Feb 06, 2025)
• Updated On: Mar 28, 2025 4:00 PM

Dr Agarwals Healthcare IPO Details

Dr Agarwals Healthcare IPO Reservation

Dr Agarwals Healthcare IPO offers 7,53,04,970 shares. 1,45,19,200 (19.28%) to QIB, 1,08,89,400 (14.46%) to NII, 2,54,08,599 (33.74%) to RII, 15,79,399 (2.1%) to employees and 2,17,78,798 (28.92%) to Anchor investors.

Category Reservation Detail Table

1. Shareholder limit: Up to Rs 2 Lakhs
2. Employee limit: Up to Rs 5 Lakhs. (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)

1. Shareholder limit: Up to Rs 2 Lakhs
2. Employee limit: Up to Rs 5 Lakhs (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
3. If applying as RII: Upto Rs. 2 lakhs
4. If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs

• Shareholder limit: Upto Rs. 2 lakhs
• If applying as RII: Upto Rs. 2 lakhs
• If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs

• Employee limit: Up to Rs 5 Lakhs (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
• If applying as RII: Upto Rs. 2 lakhs
• If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs

Dr Agarwals Healthcare IPO Anchor Investors Details

Dr Agarwals Healthcare IPO raises Rs 875.51 crore from anchor investors. Dr Agarwals Healthcare IPO Anchor bid date is January 28, 2025. Dr Agarwals Healthcare IPO Anchor Investors list

Dr Agarwals Healthcare IPO Timeline (Tentative Schedule)

Dr Agarwals Healthcare IPO opens on January 29, 2025, and closes on January 31, 2025.

Dr Agarwals Healthcare IPO Lot Size

Investors can bid for a minimum of 35 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Dr Agarwals Healthcare IPO Promoter Holding

Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue

About Dr. Agarwal’s Health Care Limited

Incorporated in 2010, Dr. Agarwal’s Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.

As of September 30, 2024, there were 737 doctors providing care to patients across the company’s facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries.

The Services provided by the company are:-

Cataract surgeries Offer cataract surgical treatments at its Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments;

Refractive surgeries: Refractive surgeries are procedures that correct eye refractive errors, helping individuals reduce or eliminate their need for glasses and contact lenses. The main types include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).

Other surgeries: Offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.

As of September 30, 2024, the company’s Indian network has 28 hubs (Tertiary Facilities, including three COEs) and 165 spokes (53 Primary and 112 Secondary Facilities).

As of September 30, 2024, the company has a presence in India across 117 metro and non-metro cities spanning 14 states and four union territories through 193 Facilities.

Competitive Strength

• Largest eye care services provider in India with a trusted brand
• End-to-end, comprehensive eye care services offering
• Scalable, asset-light, hub-and-spoke operating model
• Proven clinical excellence is driven by a strong clinical board and a history of surgical innovations. 
• Doctor-promoters leading a team of qualified medical professionals and supported by experienced management
• Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability

Company Financials

Dr. Agarwal’s Health Care Limited Financial Information (Restated Consolidated)

Key Performance Indicator (KPI)

The market capitalization of Dr Agarwals Healthcare IPO is Rs 12698.37 Cr.

KPI as of Sun, Mar 31, 2024.

• The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2024 that is available in RHP.
• The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2024 that is available in RHP.

Objects of the Issue (Dr Agarwals Healthcare IPO Objectives)

The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:

1. Repayment/prepayment, in part or full, of certain of the borrowings and
2. General corporate purposes and unidentified inorganic acquisition.

Dr Agarwals Healthcare IPO Review May apply

[Dilip Davda]  The company is engaged in eye care business providing all eye health related treatments. While its top line marked steady growth for the reported periods, it posted pressure on margins for FY23. It has nearly 25% market share in its business of eye-care related services. Based on recent financial performance, the issue appears exorbitantly priced. Only well-informed/cash surplus/risk seekers may park moderate funds for long term considering future prospects. Read detail review…

Dr Agarwals Healthcare IPO Subscription Status (Bidding Detail)

The Dr Agarwals Healthcare IPO is subscribed 1.49 times on January 31, 2025 5:04:51 PM (Day 3). The public issue subscribed 0.42 times in the retail category, 4.41 times in the QIB category, and 0.39 times in the NII category. Check Day by Day Subscription Details (Live Status)

Total Application : 2,53,169

About The Author

ipoindiaa

See author's posts